Importantly, tRiMetF31 markedly inhibited migration and angiogenesis, as well as induced apoptosis of two breast cancer cell lines, HCC1806, and MCF7, by silencing PFKFB3, although it had no effect on cancer cell proliferation. Here, PFKFB3 is linked to breast cancer.